Nature of the Disclosure
Aarti Drugs Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding scheduled analyst and institutional investor meetings, pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
- Date & Time: 20th August 2026, from 1:00 PM to 6:00 PM
- Nature of Meeting: 1x1 meetings and/or group meetings
- Organized by: Systematix
- Venue: Mumbai
- Participants: Officials of Aarti Drugs Limited will be meeting investors
Discussion Parameters
Discussions during these meetings will be based exclusively on publicly available information. The company explicitly states that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
Contingency Note
The disclosure includes a note that changes to the schedule may occur due to exigencies on the part of the host or the company.
Financial Impact
No specific financial impact, operational updates, or strategic announcements are disclosed in this filing. The document serves purely as a notice of scheduled investor meetings.